|
Clinical Trials and Observations
Citations 201-210 of 2742 total displayed.
|
Past content
(since May 1998):
|
Adverse events among 2408 unrelated donors of peripheral blood stem cells: results of a prospective trial from the National Marrow Donor Program
- Michael A. Pulsipher, Pintip Chitphakdithai, John P. Miller, Brent R. Logan, Roberta J. King, J. Douglas Rizzo, Susan F. Leitman, Paolo Anderlini, Michael D. Haagenson, Seira Kurian, John P. Klein, Mary M. Horowitz, and Dennis L. Confer
Blood 2009; 113: 3604-3611.
[Abstract]
[Full text]
[PDF]
Increased T-bet+ cytotoxic effectors and type I interferon–mediated processes in chronic graft-versus-host disease of the oral mucosa
- Matin M. Imanguli, William D. Swaim, Stacy C. League, Ronald E. Gress, Steven Z. Pavletic, and Frances T. Hakim
Blood 2009; 113: 3620-3630.
[Abstract]
[Full text]
[PDF]
Of mice and men: an open-label pilot study for treatment of immune thrombocytopenic purpura by an inhibitor of Syk
- Anna Podolanczuk, Alan H. Lazarus, Andrew R. Crow, Elliot Grossbard, and James B. Bussel
Blood 2009; 113: 3154-3160.
[Abstract]
[Full text]
[PDF]
Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: peak enhancement ratio is an independent predictor for overall survival
- Tiffany Ting-Fang Shih, Hsin-An Hou, Chieh-Yu Liu, Bang-Bin Chen, Jih-Luh Tang, Hsuan-Yu Chen, Shwu-Yuan Wei, Ming Yao, Shang-Yi Huang, Wen-Chien Chou, Szu-Chun Hsu, Woei Tsay, Chih-Wei Yu, Chao-Yu Hsu, Hwei-Fang Tien, and Pan-Chyr Yang
Blood 2009; 113: 3161-3167.
[Abstract]
[Full text]
[PDF]
Relevance of the immunoglobulin VH somatic mutation status in patients with chronic lymphocytic leukemia treated with fludarabine, cyclophosphamide, and rituximab (FCR) or related chemoimmunotherapy regimens
- Katherine I. Lin, Constantine S. Tam, Michael J. Keating, William G. Wierda, Susan O'Brien, Susan Lerner, Kevin R. Coombes, Ellen Schlette, Alessandra Ferrajoli, Lynn L. Barron, Thomas J. Kipps, Laura Rassenti, Stefan Faderl, Hagop Kantarjian, and Lynne V. Abruzzo
Blood 2009; 113: 3168-3171.
[Abstract]
[Full text]
[PDF]
Identification of a particular HIV-specific CD8+ T-cell subset with a CD27+ CD45RO–/RA+ phenotype and memory characteristics after initiation of HAART during acute primary HIV infection
- Camille Lécuroux, Isabelle Girault, Alejandra Urrutia, Jean-Marc Doisne, Christiane Deveau, Cécile Goujard, Laurence Meyer, Martine Sinet, and Alain Venet
Blood 2009; 113: 3209-3217.
[Abstract]
[Full text]
[PDF]
Pharmacogenetic study in Hodgkin lymphomas reveals the impact of UGT1A1 polymorphisms on patient prognosis
- Vincent Ribrag, Serge Koscielny, Olivier Casasnovas, Cecile Cazeneuve, Pauline Brice, Franck Morschhauser, Jean Gabarre, Aspasia Stamatoullas, Gilbert Lenoir, and Gilles Salles, on Behalf from the Groupe d'Etude des Lymphomes agressifs group, Laboratoire de Génétique et de recherche translationnelle, and Institut Gustave Roussy
Blood 2009; 113: 3307-3313.
[Abstract]
[Full text]
[PDF]
Nonmyeloablative allografting for newly diagnosed multiple myeloma: the experience of the Gruppo Italiano Trapianti di Midollo
- Benedetto Bruno, Marcello Rotta, Francesca Patriarca, Daniele Mattei, Bernardino Allione, Fabrizio Carnevale-Schianca, Roberto Sorasio, Alessandro Rambaldi, Marco Casini, Matteo Parma, Pasqua Bavaro, Francesco Onida, Alessandro Busca, Luca Castagna, Edoardo Benedetti, Anna Paola Iori, Luisa Giaccone, Antonio Palumbo, Paolo Corradini, Renato Fanin, David Maloney, Rainer Storb, Ileana Baldi, Umberto Ricardi, and Mario Boccadoro
Blood 2009; 113: 3375-3382.
[Abstract]
[Full text]
[PDF]
Long-term outcome of patients with multiple myeloma after autologous hematopoietic cell transplantation and nonmyeloablative allografting
- Marcello Rotta, Barry E. Storer, Firoozeh Sahebi, Judith A. Shizuru, Benedetto Bruno, Thoralf Lange, Edward D. Agura, Peter A. McSweeney, Michael A. Pulsipher, Parameswaran Hari, Richard T. Maziarz, Thomas R. Chauncey, Frederick R. Appelbaum, Mohamed L. Sorror, William Bensinger, Brenda M. Sandmaier, Rainer F. Storb, and David G. Maloney
Blood 2009; 113: 3383-3391.
[Abstract]
[Full text]
[PDF]
Initial therapy of acute graft-versus-host disease with low-dose prednisone does not compromise patient outcomes
- Marco Mielcarek, Barry E. Storer, Michael Boeckh, Paul A. Carpenter, George B. McDonald, H. Joachim Deeg, Richard A. Nash, Mary E. D. Flowers, Kristine Doney, Stephanie Lee, Kieren A. Marr, Terry Furlong, Rainer Storb, Frederick R. Appelbaum, and Paul J. Martin
Blood 2009; 113: 2888-2894.
[Abstract]
[Full text]
[PDF]
|
|
